Added Value of Electronic Immunization Registries in Low- and Middle-Income Countries: Observational Case Study in Tanzania

被引:3
|
作者
Secor, Andrew M. [1 ]
Mtenga, Hassan [2 ]
Richard, John [2 ]
Bulula, Ngwegwe [3 ]
Ferriss, Ellen [1 ]
Rathod, Mansi [1 ]
Ryman, Tove K. [4 ]
Werner, Laurie [1 ]
Carnahan, Emily [1 ]
机构
[1] PATH, 2201 Westlake Ave, Seattle, WA 98121 USA
[2] PATH, Dar Es Salaam, Tanzania
[3] Minist Hlth Community Dev Gender Elderly & Childr, Immunizat & Vaccine Dev Program, Dar Es Salaam, Tanzania
[4] Bill & Melinda Gates Fdn, Seattle, WA USA
来源
JMIR PUBLIC HEALTH AND SURVEILLANCE | 2022年 / 8卷 / 01期
基金
比尔及梅琳达.盖茨基金会;
关键词
immunization; immunization information system; electronic immunization registry; digital health; eHealth; CHILDHOOD IMMUNIZATION; URBAN; QUALITY; SYSTEMS;
D O I
10.2196/32455
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: There is growing interest and investment in electronic immunization registries (EIRs) in low-and middle-income countries. EIRs provide ready access to patient-and aggregate-level service delivery data that can be used to improve patient care, identify spatiotemporal trends in vaccination coverage and dropout, inform resource allocation and program operations, and target quality improvement measures. The Government of Tanzania introduced the Tanzania Immunization Registry (TImR) in 2017, and the system has since been rolled out in 3736 facilities in 15 regions. Objective: The aims of this study are to conceptualize the additional ways in which EIRs can add value to immunization programs (beyond measuring vaccine coverage) and assess the potential value-add using EIR data from Tanzania as a case study. Methods: This study comprised 2 sequential phases. First, a comprehensive list of ways EIRs can potentially add value to immunization programs was developed through stakeholder interviews. Second, the added value was evaluated using descriptive and regression analyses of TImR data for a prioritized subset of program needs. Results: The analysis areas prioritized through stakeholder interviews were population movement, missed opportunities for vaccination (MOVs), continuum of care, and continuous quality improvement. The included TImR data comprised 958,870 visits for 559,542 patients from 2359 health facilities. Our analyses revealed that few patients sought care outside their assigned facility (44,733/810,568, 5.52% of applicable visits); however, this varied by region; facility urbanicity, type, ownership, patient volume, and duration of TImR system use; density of facilities in the immediate area; and patient age. Analyses further showed that MOVs were highest among children aged <12 months (215,576/831,018, 25.94% of visits included an MOV and were applicable visits); however, there were few significant differences based on other individual or facility characteristics. Nearly half (133,337/294,464, 45.28%) of the children aged 12 to 35 months were fully vaccinated or had received all doses except measles-containing vaccine-1 of the 14-dose under-12-month schedule (ie, through measles-containing vaccine-1), and facility and patient characteristics associated with dropout varied by vaccine. The continuous quality improvement analysis showed that most quality issues (eg, MOVs) were concentrated in <10% of facilities, indicating the potential for EIRs to target quality improvement efforts. Conclusions: EIRs have the potential to add value to immunization stakeholders at all levels of the health system. Individual-level electronic data can enable new analyses to understand service delivery or care-seeking patterns, potential risk factors for underimmunization, and where challenges occur. However, to achieve this potential, country programs need to leverage and strengthen the capacity to collect, analyze, interpret, and act on the data. As EIRs are introduced and scaled in low-and middle-income countries, implementers and researchers should continue to share real-world examples and build an evidence base for how EIRs can add value to immunization programs, particularly for innovative uses.
引用
收藏
页数:24
相关论文
共 50 条
  • [21] Clinical Trial Access in Low- and Middle-Income Countries: A Case Study on India
    Desai, Aakash
    Sirohi, Bhawna
    Mathew, Aju
    [J]. CANCER INVESTIGATION, 2021, 39 (09) : 685 - 689
  • [22] A Framework for Assessing the Economic Value of Pharmacovigilance in Low- and Middle-Income Countries
    Babigumira, Joseph B.
    Stergachis, Andy
    Choi, Hye Lyn
    Dodoo, Alexander
    Nwokike, Jude
    Garrison, Louis P., Jr.
    [J]. DRUG SAFETY, 2014, 37 (03) : 127 - 134
  • [23] A Framework for Assessing the Economic Value of Pharmacovigilance in Low- and Middle-Income Countries
    Joseph B. Babigumira
    Andy Stergachis
    Hye Lyn Choi
    Alexander Dodoo
    Jude Nwokike
    Louis P. Garrison
    [J]. Drug Safety, 2014, 37 : 127 - 134
  • [24] Global food value chains and obesity in low- and middle-income countries
    Hashad, Reem
    Lim, Sunghun
    Abay, Kibrom A.
    [J]. FOOD POLICY, 2024, 127
  • [25] New medicines of added value in middle-income countries
    Born, Adam
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2014, 3 (02) : 121 - 121
  • [26] Limitations of telemedicine in low- and middle-income countries
    Kehayov, Ivo
    Uchikov, Petar
    Kitova, Tanya
    Kitov, Borislav
    [J]. NEUROSURGICAL FOCUS, 2022, 53 (03)
  • [27] Antimicrobial Stewardship in Low- and Middle-Income Countries
    Dapas, Juan Ignacio
    Quiros, Rodolfo E.
    [J]. CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES, 2018, 10 (01) : 17 - 27
  • [28] Antifungal Stewardship in Low- and Middle-Income Countries
    Fernando Riera
    Juan Pablo Caeiro
    Claudia Elena Sotomayor
    [J]. Current Treatment Options in Infectious Diseases, 2019, 11 : 292 - 299
  • [29] Infant Nutrition in Low- and Middle-Income Countries
    Javaid, Aamir
    Syed, Sana
    [J]. CLINICS IN PERINATOLOGY, 2022, 49 (02) : 475 - 484
  • [30] Infective Endocarditis in Low- and Middle-Income Countries
    Njuguna, Benson
    Gardner, Adrian
    Karwa, Rakhi
    Delahaye, Francois
    [J]. CARDIOLOGY CLINICS, 2017, 35 (01) : 153 - +